trending Market Intelligence /marketintelligence/en/news-insights/trending/btm4hpyWe11aNQpkEpBYqQ2 content esgSubNav
In This List

AmerisourceBergen's Xcenda to acquire technology company Dymaxium

Blog

Insight Weekly: Cryptocurrency's growth; green bond market outlook; coal investors' windfall

Blog

Global M&A By the Numbers: Q1 2022

Blog

Insight Weekly: Challenges for European banks; Japan's IPO slowdown; carmakers' supply woes

Blog

Investment Banking Essentials Newsletter April Edition - 2022


AmerisourceBergen's Xcenda to acquire technology company Dymaxium

AmerisourceBergen Corp.'s unit Xcenda LLC will acquire technology solutions company Dymaxium.

Dymaxium, through its online platform, FormularyDecisions.com, provides healthcare payers access to clinical evidence and economic product information that helps with assessing and evaluating products.

Dymaxium's platform has over 2,100 registered U.S. payers and healthcare decision-makers along with more than 2,300 products approved by the U.S. Food and Drug Administration.